Study analysis · Frontiers in Microbiology · 2026
The gut bacteria of 100-year-olds are unlike any you've heard of—and most can't be used as probiotics.
People who live to 100 have 12 special gut bacteria that young people don't have, but 60% of them resist antibiotics, so you can't take them as supplements.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at the good bacteria in the guts of old people and young people and found they were different. But it didn’t change anyone’s diet or give anyone probiotics—it just noticed what was already there. So we can’t say the bacteria made people live longer, only that they’re different in people who did.
What’s the bottom line?
Scientists looked at the good bacteria in the guts of 100-year-olds and 20-year-olds to see what’s special about the super-old.
How strong is this study?
The scientists did a good job carefully identifying and testing the bacteria, but they only looked at 50 people total, and those old people were super healthy—so we can’t say this applies to everyone. Also, they tested the bacteria in a lab, not in real bodies, so we don’t know if what happened in the test tube happens inside you.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
24 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=50)+4.4/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is a cross-sectional study comparing two groups at a single time point; it cannot determine whether differences in lactobacilli caused healthy aging or resulted from it. Temporal direction and confounding factors (e.g., diet, medication, lifestyle) cannot be ruled out.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the study text. The research appears to be independently conducted without industry involvement.
The study lacks any declared funding sources or conflict of interest statement. While the methodology is rigorous and transparent, the absence of funding disclosure raises a minor transparency concern, though no evidence of bias or industry influence is present.
Key takeaways
- 01
Centenarians had 12 unique types of Lactobacillus bacteria that young people didn’t have.
- 02
These bacteria ate different sugars (like L-arabinose from potatoes) and made different chemicals (like acylcarnitines).
- 03
But 60% of all Lactobacillus strains were resistant to antibiotics like kanamycin.
- 04
These bacteria may help healthy aging by changing how the body processes fats and sugars, but their antibiotic resistance makes them unsafe to use as probiotics.
Surprising findings
- Arachidonic acid—often labeled as 'inflammatory'—was elevated in centenarians' gut bacteria.Most health content warns against omega-6 fats like arachidonic acid, but here it's linked to longevity. The study suggests it may have protective roles in aging, contradicting mainstream narratives.
- Lactobacillus strains from centenarians were more likely to be 'nomadic' or environmental—meaning they likely came from food, not human evolution.We assume our gut bacteria are inherited or evolved with us, but this suggests centenarians' longevity may be tied to dietary exposure (like fermented foods) rather than genetics.
Practical takeaways
Eat more whole plant foods like potatoes, whole grains, and legumes—they contain L-arabinose and L-fucose, which may feed longevity-linked bacteria.
You can't replicate this by taking probiotics—most commercial strains don't match these unique species, and many are already antibiotic-resistant.
medium confidenceAvoid assuming all 'natural' or 'fermented' probiotics are safe—check if they're tested for antibiotic resistance.
This study only tested 18 strains for metabolism; results may not apply to all centenarians or populations.
low confidenceWhy this study matters
Centenarians Have 12 Unique Gut Bacteria
Centenarians hosted 12 unique Lactobacillus species not found in young adults, while young adults had only 2 unique strains. Overall, 20 species were identified, with 6 shared between groups.
This suggests a specific microbial fingerprint may be linked to extreme longevity—offering a new way to understand healthy aging beyond diet or exercise.
They Eat Different Sugars
Lactobacillus from centenarians preferentially fermented plant sugars like L-arabinose (found in potatoes and grains) and L-fucose (produced by human cells), while young adults' strains fermented common sugars like maltose and turanose (found in honey and processed foods).
It’s not just what you eat—it’s what your gut bugs *can* digest. This could explain why whole-food diets correlate with longevity.
Their Bacteria Make 'Anti-Aging' Chemicals
Centenarians' bacteria produced higher levels of acylcarnitines (linked to fat metabolism), arachidonic acid (an omega-6 fatty acid), and bile acids like lithocholic acid—compounds associated with reduced inflammation and cognitive health.
These aren't just random byproducts—they're metabolites that may help the body burn fat efficiently and protect the brain, even in old age.
60% Are Antibiotic-Resistant—No Probiotics Here
Over 60% of all Lactobacillus strains from both groups were resistant to kanamycin, and nearly 25% resisted clindamycin, chloramphenicol, or vancomycin. Only 23.4% were sensitive to all tested antibiotics.
This shatters the myth that 'all good bacteria are probiotic-ready.' Most natural strains are unsafe to ingest as supplements.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at the good bacteria in the guts of 100-year-olds and 20-year-olds to see what’s special about the super-old.
Research results
Centenarians had 12 unique types of Lactobacillus bacteria that young people didn’t have. These bacteria ate different sugars (like L-arabinose from potatoes) and made different chemicals (like acylcarnitines). But 60% of all Lactobacillus strains were resistant to antibiotics like kanamycin.
What this means - more context
These bacteria may help healthy aging by changing how the body processes fats and sugars, but their antibiotic resistance makes them unsafe to use as probiotics.
This study compares culturable Lactobacillus strains in centenarians and young adults to identify microbial signatures and probiotic potential linked to exceptional longevity.
Centenarians showed greater species richness of culturable Lactobacillus (12 unique species vs. 2 in young adults), distinct carbohydrate fermentation (L-arabinose/L-fucose vs. maltose/turanose), and altered metabolic profiles (higher acylcarnitines, arachidonic acid, bile acids). Over 60% of strains were resistant to kanamycin, limiting probiotic suitability.
Methods Used
Culture-based isolation of Lactobacillus from fecal samples of 25 centenarians and 25 young adults; species identification via 16S rRNA sequencing; antibiotic susceptibility testing (E-test); biochemical profiling (API 50 CH); metabolomic analysis of culture supernatants using LC-MS/MS.
Main Finding
Centenarians harbor a more diverse culturable Lactobacillus community with unique species and metabolic traits, but most strains exhibit intrinsic antibiotic resistance, reducing their viability as probiotics.
Confidence Level
Moderate — findings are robust within the sample (n=50), but metabolomic and biochemical analyses were limited to only 18 antibiotic-sensitive strains (≈25% of total), reducing statistical power.
Study Flags
Red Flags
- •Small sample size for metabolic analysis (n=18 antibiotic-sensitive strains)
- •High antibiotic resistance (>60% resistant to kanamycin) limits probiotic applicability
- •No longitudinal or intervention design — cannot prove causation
Surprising Findings
Arachidonic acid—often labeled as 'inflammatory'—was elevated in centenarians' gut bacteria.
Most health content warns against omega-6 fats like arachidonic acid, but here it's linked to longevity. The study suggests it may have protective roles in aging, contradicting mainstream narratives.
Practical Takeaways
Eat more whole plant foods like potatoes, whole grains, and legumes—they contain L-arabinose and L-fucose, which may feed longevity-linked bacteria.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at the good bacteria in the guts of old people and young people and found they were different. But it didn’t change anyone’s diet or give anyone probiotics—it just noticed what was already there. So we can’t say the bacteria made people live longer, only that they’re different in people who did.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Detailed culture-based isolation and identification of lactobacilli to species level
- Use of multiple analytical methods (MALDI-TOF, 16S sequencing, API 50 CH, metabolomics)
- Standardized antibiotic susceptibility testing per EFSA guidelines
Weaknesses
- Cross-sectional design prevents inference of causality or directionality
- Small sample size reduces statistical power, especially for subgroup analyses
- No control for diet, medication, or lifestyle confounders
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists looked at the good bacteria in the guts of 100-year-olds and 20-year-olds to see what’s special about the super-old.
Research results
Centenarians had 12 unique types of Lactobacillus bacteria that young people didn’t have. These bacteria ate different sugars (like L-arabinose from potatoes) and made different chemicals (like acylcarnitines). But 60% of all Lactobacillus strains were resistant to antibiotics like kanamycin.
What this means - more context
These bacteria may help healthy aging by changing how the body processes fats and sugars, but their antibiotic resistance makes them unsafe to use as probiotics.
This study compares culturable Lactobacillus strains in centenarians and young adults to identify microbial signatures and probiotic potential linked to exceptional longevity.
Centenarians showed greater species richness of culturable Lactobacillus (12 unique species vs. 2 in young adults), distinct carbohydrate fermentation (L-arabinose/L-fucose vs. maltose/turanose), and altered metabolic profiles (higher acylcarnitines, arachidonic acid, bile acids). Over 60% of strains were resistant to kanamycin, limiting probiotic suitability.
Methods Used
Culture-based isolation of Lactobacillus from fecal samples of 25 centenarians and 25 young adults; species identification via 16S rRNA sequencing; antibiotic susceptibility testing (E-test); biochemical profiling (API 50 CH); metabolomic analysis of culture supernatants using LC-MS/MS.
Main Finding
Centenarians harbor a more diverse culturable Lactobacillus community with unique species and metabolic traits, but most strains exhibit intrinsic antibiotic resistance, reducing their viability as probiotics.
Confidence Level
Moderate — findings are robust within the sample (n=50), but metabolomic and biochemical analyses were limited to only 18 antibiotic-sensitive strains (≈25% of total), reducing statistical power.
Study Flags
Red Flags
- •Small sample size for metabolic analysis (n=18 antibiotic-sensitive strains)
- •High antibiotic resistance (>60% resistant to kanamycin) limits probiotic applicability
- •No longitudinal or intervention design — cannot prove causation
Surprising Findings
Arachidonic acid—often labeled as 'inflammatory'—was elevated in centenarians' gut bacteria.
Most health content warns against omega-6 fats like arachidonic acid, but here it's linked to longevity. The study suggests it may have protective roles in aging, contradicting mainstream narratives.
Practical Takeaways
Eat more whole plant foods like potatoes, whole grains, and legumes—they contain L-arabinose and L-fucose, which may feed longevity-linked bacteria.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Moderate probability
on the GRADE evidence scale
This study looked at the good bacteria in the guts of old people and young people and found they were different. But it didn’t change anyone’s diet or give anyone probiotics—it just noticed what was already there. So we can’t say the bacteria made people live longer, only that they’re different in people who did.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Detailed culture-based isolation and identification of lactobacilli to species level
- Use of multiple analytical methods (MALDI-TOF, 16S sequencing, API 50 CH, metabolomics)
- Standardized antibiotic susceptibility testing per EFSA guidelines
Weaknesses
- Cross-sectional design prevents inference of causality or directionality
- Small sample size reduces statistical power, especially for subgroup analyses
- No control for diet, medication, or lifestyle confounders
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The scientists did a good job carefully identifying and testing the bacteria, but they only looked at 50 people total, and those old people were super healthy—so we can’t say this applies to everyone. Also, they tested the bacteria in a lab, not in real bodies, so we don’t know if what happened in the test tube happens inside you.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
24 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=50)+4.4/20
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 544 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is a cross-sectional study comparing two groups at a single time point; it cannot determine whether differences in lactobacilli caused healthy aging or resulted from it. Temporal direction and confounding factors (e.g., diet, medication, lifestyle) cannot be ruled out.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the study text. The research appears to be independently conducted without industry involvement.
The study lacks any declared funding sources or conflict of interest statement. While the methodology is rigorous and transparent, the absence of funding disclosure raises a minor transparency concern, though no evidence of bias or industry influence is present.